Literature DB >> 11935148

Uncoupling protein-2: evidence for its function as a metabolic regulator.

M C Saleh1, M B Wheeler, C B Chan.   

Abstract

Uncoupling protein-2, discovered in 1997, belongs to a family of inner mitochondrial membrane proteins that, in general, function as carriers. The function(s) of uncoupling protein-2 have not yet been definitively described. However, mounting evidence suggests that uncoupling protein-2 could act in multiple tissues as a regulator of lipid metabolism. A role as a modulator of reactive oxygen species as a defence against infection is also postulated. In this review, a brief overview of the general and specific properties of uncoupling protein-2 is given and evidence for metabolic and immune regulatory functions is summarized. Uncoupling protein-2 could have particular importance in the regulation of lipid metabolism in adipose tissue and skeletal muscle. In addition, its ability to inhibit insulin secretion could also promote fat utilization over storage. Inhibition by uncoupling protein-2 of reactive oxygen species formation in macrophages and other tissues could have implications for regulation of immune function. The possibility of functions of uncoupling protein-2 in other tissues such as the brain are beginning to emerge.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11935148     DOI: 10.1007/s00125-001-0737-x

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  24 in total

Review 1.  The role of uncoupling protein 3 in human physiology.

Authors:  W Timothy Garvey
Journal:  J Clin Invest       Date:  2003-02       Impact factor: 14.808

2.  Functional and morphological alterations of mitochondria in pancreatic beta cells from type 2 diabetic patients.

Authors:  M Anello; R Lupi; D Spampinato; S Piro; M Masini; U Boggi; S Del Prato; A M Rabuazzo; F Purrello; P Marchetti
Journal:  Diabetologia       Date:  2005-01-15       Impact factor: 10.122

Review 3.  Uncoupling proteins: role in insulin resistance and insulin insufficiency.

Authors:  Catherine B Chan; Mary-Ellen Harper
Journal:  Curr Diabetes Rev       Date:  2006-08

4.  Cellular stress responses: cell survival and cell death.

Authors:  Simone Fulda; Adrienne M Gorman; Osamu Hori; Afshin Samali
Journal:  Int J Cell Biol       Date:  2010-02-21

5.  ESR1, FTO, and UCP2 genes interact with bariatric surgery affecting weight loss and glycemic control in severely obese patients.

Authors:  Tsan-Hon Liou; Hsin-Hung Chen; Weu Wang; Shu-Fen Wu; Yi-Chih Lee; Wei-Shiung Yang; Wei-Jei Lee
Journal:  Obes Surg       Date:  2011-11       Impact factor: 4.129

6.  A mixture of the aqueous extract of Garcinia cambogia, soy peptide and L: -carnitine reduces the accumulation of visceral fat mass in rats rendered obese by a high fat diet.

Authors:  Yun Jung Kim; Keun-Young Kim; Min Sun Kim; Jin Hee Lee; Kang Pyo Lee; Taesun Park
Journal:  Genes Nutr       Date:  2008-02       Impact factor: 5.523

Review 7.  Ghrelin forms in the modulation of energy balance and metabolism.

Authors:  Gianluca Gortan Cappellari; Rocco Barazzoni
Journal:  Eat Weight Disord       Date:  2018-10-24       Impact factor: 4.652

Review 8.  The polymorphisms of UCP1 genes associated with fat metabolism, obesity and diabetes.

Authors:  Jun-jing Jia; Yun-bo Tian; Zhen-hui Cao; Lin-li Tao; Xi Zhang; Si-zhen Gao; Chang-rong Ge; Qiu-Ye Lin; M Jois
Journal:  Mol Biol Rep       Date:  2009-05-15       Impact factor: 2.316

9.  Deletion of the alpha-arrestin protein Txnip in mice promotes adiposity and adipogenesis while preserving insulin sensitivity.

Authors:  William A Chutkow; Andreas L Birkenfeld; Jonathan D Brown; Hui-Young Lee; David W Frederick; Jun Yoshioka; Parth Patwari; Romy Kursawe; Samuel W Cushman; Jorge Plutzky; Gerald I Shulman; Varman T Samuel; Richard T Lee
Journal:  Diabetes       Date:  2010-03-18       Impact factor: 9.461

10.  Lifestyle changes and lipid metabolism gene expression and protein content in skeletal muscle of subjects with impaired glucose tolerance.

Authors:  M Mensink; E E Blaak; H Vidal; T W A De Bruin; J F C Glatz; W H M Saris
Journal:  Diabetologia       Date:  2003-07-11       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.